Author

Iago Rodríguez-Lago

UEG Week+ | Burnout in European Gastroenterology - A call to action
UEG Week+ | Burnout in European Gastroenterology - A call to action

Iago Rodríguez-Lago  et al.

RISK OF PROGRESSION OF PRECLINICAL ULCERATIVE COLITIS
RISK OF PROGRESSION OF PRECLINICAL ULCERATIVE COLITIS

Iago Rodríguez-Lago  et al.

TRANSMURAL CROSS-SECTIONAL FINDINGS AND BOWEL DAMAGE ASSESSMENT IN PRECLINICAL CROHN’S DISEASE: A CASE-CONTROL STUDY
TRANSMURAL CROSS-SECTIONAL FINDINGS AND BOWEL DAMAGE ASSESSMENT IN PRECLINICAL CROHN’S DISEASE: A CASE-CONTROL STUDY

Iago Rodríguez-Lago  et al.

Introduction to the first paper on: IBD
Introduction to the first paper on: IBD

Iago Rodríguez-Lago

CHARACTERISTICS AND MANAGEMENT OF PYODERMA GANGRENOSUM AND ERYTHEMA NODOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PIONOSO MULTICENTER STUDY
CHARACTERISTICS AND MANAGEMENT OF PYODERMA GANGRENOSUM AND ERYTHEMA NODOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PIONOSO MULTICENTER STUDY

Iago Rodríguez-Lago  et al.

SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY
SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY

Iago Rodríguez-Lago  et al.

LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU
LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU

Iago Rodríguez-Lago

SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY
SUBCLINICAL INFLAMMATORY BOWEL DISEASE PRECEDES THE DIAGNOSIS AND LEADS TO AN INCREASE IN HEALTHCARE RESOURCES UTILIZATION: MULTICENTER CASE-CONTROL STUDY

SEROLOGIC RESPONSE WITH ANTIMICROBIAL ANTIBODIES DURING THE PRECLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE
SEROLOGIC RESPONSE WITH ANTIMICROBIAL ANTIBODIES DURING THE PRECLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE

European guidelines on microscopic colitis: UEG and European Microscopic Colitis Group (EMCG) statements and recommendations
European guidelines on microscopic colitis: UEG and European Microscopic Colitis Group (EMCG) statements and recommendations

Iago Rodríguez-Lago  et al.

International consensus on methodological issues in standardization of fecal calprotectin measurement in IBD
International consensus on methodological issues in standardization of fecal calprotectin measurement in IBD

Iago Rodríguez-Lago  et al.

SEROLOGIC RESPONSE WITH ANTIMICROBIAL ANTIBODIES DURING THE PRECLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE
SEROLOGIC RESPONSE WITH ANTIMICROBIAL ANTIBODIES DURING THE PRECLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE

Iago Rodríguez-Lago  et al.

Angiotensin receptor blockers: its influence in patients on a gluten-free diet
Angiotensin receptor blockers: its influence in patients on a gluten-free diet

Iago Rodríguez-Lago

Risk factors, epidemiology and prognosis of cholangiocarcinoma
Risk factors, epidemiology and prognosis of cholangiocarcinoma

Iago Rodríguez-Lago

Fecal microbiota transplantation and the impact of COVID-19
Fecal microbiota transplantation and the impact of COVID-19

Iago Rodríguez-Lago  et al.

Autoimmune pancreatitis and inflammatory bowel disease
Autoimmune pancreatitis and inflammatory bowel disease

Iago Rodríguez-Lago  et al.

LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU
LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU

Iago Rodríguez-Lago  et al.

Functional bowel disorders with diarrhoea: UEG and ESNM guidelines
Functional bowel disorders with diarrhoea: UEG and ESNM guidelines

Iago Rodríguez-Lago  et al.

Are we providing the correct pancreatic enzyme treatment in chronic pancreatitis?
Are we providing the correct pancreatic enzyme treatment in chronic pancreatitis?

Iago Rodríguez-Lago  et al.

LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN'S DISEASE: ECUFIT STUDY FROM GETECCU
LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN'S DISEASE: ECUFIT STUDY FROM GETECCU

Item 1 - 20 / 57
1
2 3